🇺🇸 FDA
Patent

US 8003685

Thiophene analogues for the treatment or prevention of flavivirus infections

granted A61KA61K38/005A61K38/21

Quick answer

US patent 8003685 (Thiophene analogues for the treatment or prevention of flavivirus infections) held by Vertex Pharmaceuticals (Canada) Incorporated expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals (Canada) Incorporated
Grant date
Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/005, A61K38/21, A61P, A61P1/16